By Editor, Concierge Medicine Today History is important to all of us. We learn from it and we many of our futures are shaped by it. A lot has happened in the […]
By Editor, Concierge Medicine Today History is important to all of us. We learn from it and we many of our futures are shaped by it. A lot has happened in the […]
Membership fees, smaller panels, and a different financial structure entirely. Here’s what physicians need to understand before the math becomes a surprise. CMT Knowledge Library | Educational Reference | Updated April 2026 […]
As the saying goes — and it still holds true — the best physician leaders are readers. By Editor-in-Chief, Concierge Medicine Today My wife has a standing joke in our home: I […]
Turns out AI had a detailed answer. And the model it described is real, federally funded, clinically proven, and already reshaping how acute care gets delivered in America. Published by Concierge Medicine […]
History matters. Not because the past is perfect, but because it is instructive — and because the industry we are part of today was built by real decisions, made by real physicians, […]
Most patient complaints are not about clinical competency. They’re about how patients were made to feel. If your practice isn’t actively managing that gap, you’re not managing your reputation — you’re just […]
A field guide for health system leaders, administrators, and physicians — with verified data, updated program listings, and a clear explanation of the distinctions that matter. By Michael Tetreault, Editor-in-Chief, Concierge Medicine […]
CHICAGO (March 17, 2026) — The American Medical Association (AMA) applauds the introduction of bipartisan legislation to exempt physicians and other health care professionals from the $100,000 filing fee on new H-1B […]
Both compassion fatigue and burnout have been major problems in the medical community for some time, and the pandemic only exacerbated this issue. By Dr. Una, EntreMD Business School These terms are […]
The study, which was designed to evaluate safety and biological effects, enrolled 24 men with high-risk, localized prostate cancer and found that adding the investigational Fc-enhanced anti-CTLA-4 antibody BMS-986218 to hormone therapy […]